The Latest Breaking News on Pharma

Revance Therapeutics, a biotech stock, reported earnings late Tuesday. Shares are tanking after the numbers surprised investors.

As a slowdown in monetary policy tightening is paving its way, the possibility of a soft landing still stands. Therefore, it could be an ideal opportunity for investors to load up on some fundamentally sound growth stocks, Novartis (NVS), Daimler Truck Holding (DTRUY), and CPI Aerostructures (CVU). Read on….

The Police Association says alternative policy could have been pushed through in order to enable roadside drug testing on time.

Government proposals to improve access to primary care are expected on Tuesday.

MedAvail Holdings’ (MDVL) net loss widened by nearly 9% in fiscal 2022. The company has been taking some measures to achieve profitability, but it still looks far away. Amid this backdrop, investors could consider avoiding the stock. Read more….

Shares of PTGX stock briefly broke out Friday after Protagonist said it plans to soon present new test results for its psoriasis drug.

U.S. health regulators are weighing the first-ever request to make a birth control pill available without a prescription

One of the firm's long term shareholders has tabled an offer

Officials say an explosion at a pharmaceutical plant in Massachusetts left one worker missing and sent four people to the hospital as a precaution